ÂÜÀòÂÒÂ×

Clarence T. Wade, MBA has over 15 years of experience in the pharmaceutical and healthcare industry. Clarence T. is currently serving as the Senior Director of Health Economics Outcomes Research (HEOR) at SK Life Science, Inc. In this role, they are responsible for conducting research on the economic impact and outcomes of healthcare interventions.

Previously, Clarence worked at Recro Pharma, Inc. as the Director of National Accounts. Clarence T. led the profiling of integrated delivery networks (IDNs) to identify opportunities for the company's investigational pain drug, IV Meloxicam. Clarence T. created and disseminated healthcare economic information (HCEI) messages to pharmacy and therapeutics (P&T) members and had meetings with key opinion leaders (KOLs) at various prestigious healthcare institutions.

Prior to that, Clarence held the position of Director of Health Systems-Market Access at La Jolla Pharmaceutical Company. Clarence T. played a key role in market access strategy and planning, targeting health systems for the company's products.

Clarence also has experience as a National IDN Manager Oncology Market Access at NanoString Technologies, Inc. In this role, they acted as a single point of contact for integrated delivery networks (IDNs) and was responsible for promoting and increasing the utilization of the company's breast cancer assay, Prosigna, among various healthcare stakeholders.

Before joining NanoString Technologies, Clarence worked as a Regional Oncology Manager at EMD Serono, Inc. where they collaborated with Pfizer to promote and educate healthcare providers on Xalkori, a treatment for non-small cell lung cancer (NSCLC).

Clarence's career also includes positions at Shire, Johnson & Johnson, and AbbVie, where they held various marketing and management roles in the fields of regenerative medicine, wound care, oncology diagnostics, and neuroscience.

Overall, Clarence has a strong background in market access, health economics, and outcomes research, with a focus on promoting and increasing utilization of innovative healthcare products and technologies.

Clarence T. Wade pursued an MBA from Virginia Tech from 1997 to 1999. Prior to that, they attended the University of Dayton. However, specific details such as the degree or field of study are not provided for both educational experiences.